Acute Myeloid Leukemia Research
Acute Myeloid Leukemia Research is a research topic within Hematology. Science Explorer counts 51k research works in it since 1950. 14.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, management, and genomic classification of Acute Myeloid Leukemia (AML). It covers topics such as prognostic factors, clonal hematopoiesis, FLT3 mutations, epigenetic landscapes, therapeutic trials, and the role of hematopoietic stem cells in AML.
- Acute Myeloid Leukemia
- AML
- Genomic Classification
- Myeloid Neoplasms
- Prognostic Factors
- Clonal Hematopoiesis
- FLT3 Mutations
- Epigenetic Landscapes
- Therapeutic Trials
- Hematopoietic Stem Cells
- Research works
- 51k fractional, since 1950
- In the world top 10%
- 7.7k per year above
- Top-10% rate
- 14.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +28% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Acute Myeloid Leukemia Research research?
By volume, the United States and China publish the most (3.3k and 1.7k works in 2022–2025).
By volume, 2022–2025
- 1 United States 3.3k works
- 2 China 1.7k works
- 3 Germany 494 works
- 4 Brazil 449 works
- 5 Japan 433 works
- 6 Italy 432 works
- 7 India 372 works
- 8 France 342 works
- 9 United Kingdom 306 works
- 10 Spain 284 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Acute Myeloid Leukemia Research research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Acute Myeloid Leukemia Research research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Moffitt Cancer Center.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 293 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 78 works
- 3 Moffitt Cancer CenterUnited States 69 works
- 4 Institute of Hematology & Blood Diseases HospitalChina 65 works
- 5 Memorial Sloan Kettering Cancer CenterUnited States 50 works
- 6 Dana-Farber Cancer InstituteUnited States 50 works
- 7 Cleveland ClinicUnited States 49 works
- 8 Washington University in St. LouisUnited States 47 works
- 9 St. Jude Children's Research HospitalUnited States 44 works
- 10 Soochow UniversityChina 42 works
Who are the leading researchers in Acute Myeloid Leukemia Research?
The most-cited researchers publishing on Acute Myeloid Leukemia Research include Kenneth J. Livak, Benjamin L. Ebert and Gad Getz.
- 1 Kenneth J. Livak United States 20k citations
- 2 Benjamin L. Ebert United States 6.7k citations
- 3 Gad Getz United States 6.2k citations
- 4 Hagop M. Kantarjian United States 4k citations
- 5 Ruth J. F. Loos United States 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Acute Myeloid Leukemia Research research done?
The largest centres of Acute Myeloid Leukemia Research research in 2022–2025 are Houston (United States), Beijing (China), New York (United States) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Duarte, Lancaster and Houston.
Largest cities, 2022–2025
Where it is the local speciality
- DuarteUS · 22.3 works40×
- LancasterUS · 25.5 works32×
- HoustonUS · 356.1 works14×
- The BronxUS · 46.2 works14×
Location quotient: how much more of its research is in Acute Myeloid Leukemia Research than the world average.
Where is the best place to study Acute Myeloid Leukemia Research?
Among universities, judged by research, Center for Life Sciences, Albert Einstein College of Medicine and University of Colorado Anschutz Medical Campus score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Center for Life SciencesChina | 69.8 | 28.4% | 18.5× | 10 | +384.7% |
| 2 | Albert Einstein College of MedicineUnited States | 59.4 | 19.3% | 13.7× | 25 | +92.5% |
| 3 | University of Colorado Anschutz Medical CampusUnited States | 55.3 | 14.1% | 8.5× | 23 | +414.2% |
| 4 | Oregon Health & Science UniversityUnited States | 53.1 | 12.7% | 9.7× | 29 | +101.0% |
| 5 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 50.8 | 10.4% | 8.1× | 78 | +79.6% |
| 6 | Medizinische Hochschule HannoverGermany | 50.2 | 21.6% | 9.0× | 19 | -14.7% |
| 7 | Washington University in St. LouisUnited States | 49.0 | 19.7% | 6.7× | 48 | +20.0% |
| 8 | Icahn School of Medicine at Mount SinaiUnited States | 48.5 | 16.2% | 6.4× | 31 | +102.0% |
| 9 | Heidelberg UniversityGermany | 47.3 | 25.5% | 4.4× | 23 | +24.5% |
| 10 | Baylor College of MedicineUnited States | 47.2 | 24.6% | 6.1× | 24 | +15.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Acute Myeloid Leukemia Research research growing?
Output in 2018–2022 was 28% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Acute Myeloid Leukemia Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.